Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the drug delivery devices market size evolved in recent years?

The market size of drug delivery devices has seen robust growth in the past few years. Its size is expected to increase from $91.03 billion in 2024 to $96.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth in the historic period include the rapid increase in the aging population, expansion of healthcare facilities, economic expansion in developing markets, and a rise in healthcare spending.

What are the predictions for the drug delivery devices market size in the coming years?

The market size of farm machinery and equipment is anticipated to witness robust expansion in the upcoming years; the growth estimates suggest a surge to $295.1 billion by 2029 with a compound annual growth rate (CAGR) of 5.8%. Contributory factors to this growth during the projected period include advances in precision farming, robotics and automation, the Internet of Things (IoT) and data analytics, as well as eco-friendly farming solutions, and the utilization of electric and hybrid machinery. The future trends to look out for include the traceability provided by blockchain, the use of robotics in the harvesting and planting process, adoption of hydroponics and aeroponics technologies, implementation of multi-functional tools, and remote monitoring and controlling methods.

Get your drug delivery devices market report here!

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What key factors are fueling the growth of the drug delivery devices market?

The escalating occurrence of chronic illnesses such as cardiovascular diseases, diabetes, cancer and other ailments is anticipated to fuel the growth of the drug delivery devices market. For example, data from the National Library of Medicine, a US-based medical library governed by the federal government, in January 2023 projected a 99.5% surge in Americans aged 50 and above with at least one chronic disease. The numbers are expected to jump from 71.522 million in 2020 to 142.66 million by 2050. Diverse methods are employed for the administration of medical drugs. The invention of new drug delivery systems is a vital process in the pharmaceutical industry. Globally, there is a rise in research and development (R&D) in drug delivery due to the rising occurrence of these diseases. A majority of the pharmaceutical firms are concentrating on developing various drug delivery technologies to ensure superior benefits and improved results for their marketed products. Therefore, the escalating occurrence of chronic illnesses leads to a surge in the utilization of therapeutic drugs and therapies, which in turn, is anticipated to drive the growth of the drug delivery devices market.

How is the global drug delivery devices market divided into key segments?

The drug delivery devices market covered in this report is segmented –

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:

1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Who are the key firms paving the way for growth in the drug delivery devices market?

Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Which trends are expected to transform the drug delivery devices market?

Major drug delivery device market players are concentrating on the innovation of devices such as autoinjectors with fully integrated connectivity for a competitive advantage in the industry. Autoinjectors, designed for self-medication with coordinated doses, are rapidly evolving. For instance, Jabil Healthcare, based in the US and known for its healthcare manufacturing solutions, introduced the Qfinity autoinjector platform in May 2022. This reusable drug delivery device stands distinguished as a straightforward, reusable, and modular solution for self-injection of subcutaneous drugs. It serves as a cost-effective rival to other market players while endorsing sustainable medicine delivery in the pharmaceutical sector. The device’s adaptable design accommodates diverse drug volumes and viscosities, and its patient-friendly design leads to up to 65% lesser expenditure per injection compared to top disposable autoinjectors. The robust Qfinity device is capable of over 100 injections using 1 mL or 2.25 mL pre-loaded disposable cassettes. Besides, with reduced component and material usage, it offers an estimated cost reduction of 65% per injection, a 60% smaller carbon footprint, a 50% production footprint reduction, and a 70% decrease in capital expenditure (CAPEX).

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

What regions are contributing significantly to the growth of the drug delivery devices market?

North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Drug Screening Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Medical Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

Implantable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: